Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients

• Raquel Catarino ,

  * E-mail: raquelcatarino@yahoo.com

  Affiliation Molecular Oncology Group Investigation Center, Portuguese Institute of Oncology, Porto, Portugal

  ⨯
• Ana Coelho,

  Affiliation Molecular Oncology Group Investigation Center, Portuguese Institute of Oncology, Porto, Portugal

  ⨯
• António Araújo,

  Affiliation Medical Oncology Department, Portuguese Institute of Oncology, Porto, Portugal

  ⨯
• Mónica Gomes,

  Affiliation Molecular Oncology Group Investigation Center, Portuguese Institute of Oncology, Porto, Portugal

  ⨯
• Augusto Nogueira,

  Affiliation Molecular Oncology Group Investigation Center, Portuguese Institute of Oncology, Porto, Portugal

  ⨯
• Carlos Lopes,

  Affiliations Molecular Oncology Group Investigation Center, Portuguese Institute of Oncology, Porto, Portugal, Abel Salazar Institute for the Biomedical Sciences, Porto, Portugal

  ⨯
• Rui Medeiros

  Affiliations Molecular Oncology Group Investigation Center, Portuguese Institute of Oncology, Porto, Portugal, Abel Salazar Institute for the Biomedical Sciences, Porto, Portugal, Research Department, Portuguese League Against Cancer (Norte), Porto, Portugal, Faculty of Health Sciences of Fernando Pessoa University, CEBIMED, Porto, Portugal

  ⨯